Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 35.15
-1.60 (-4.35%)
May 29, 2026, 3:00 PM CST
95.71% (1Y)
| Market Cap | 14.26B +119.7% |
| Revenue (ttm) | 774.47M +27.9% |
| Net Income | 56.52M +42.4% |
| EPS | 0.14 +42.6% |
| Shares Out | 405.71M |
| PE Ratio | 251.94 |
| Forward PE | 195.28 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,405,501 |
| Open | 36.50 |
| Previous Close | 36.75 |
| Day's Range | 35.00 - 37.50 |
| 52-Week Range | 15.41 - 41.63 |
| Beta | 0.39 |
| Analysts | Strong Buy |
| Price Target | 28.00 (-20.34%) |
| Earnings Date | Apr 30, 2026 |